Ikena Oncology News

Ikena Oncology | 8-K: Current report

Jun 11 04:11

Ikena Oncology | 8-K: Current report

May 29 04:32

Ikena Oncology | DEFA14A: Others

Apr 27 04:37

Ikena Oncology | DEF 14A: Definitive information statements

Apr 27 04:26

Ikena Oncology | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 12 19:52

Ikena Oncology | 8-K: Current report

Feb 22 05:39

Ikena Oncology | 8-K: Current report

Jan 18 13:00

Ikena Oncology | 8-K: Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results

Nov 9, 2023 20:09

Ikena Oncology | 8-K: Current report

Oct 12, 2023 05:10

Ikena Oncology | DEF 14A: Definitive information statements

Sep 26, 2023 04:05

Ikena Oncology | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Sep 16, 2023 04:05

Ikena Oncology | S-3: Registration statement for specified transactions by certain issuers

Aug 19, 2023 04:02

Ikena Oncology | 8-K: Current report

Aug 7, 2023 20:02

Ikena Oncology | 8-K: Current report

Jul 1, 2023 05:15

Ikena Oncology | 8-K: Current report

Jun 10, 2023 04:26

Ikena Oncology | 8-K: Current report

May 15, 2023 21:09

Ikena Oncology | DEFA14A: Others

Apr 28, 2023 20:20

Ikena Oncology | DEF 14A: Definitive proxy statements

Apr 28, 2023 20:17

Ikena Oncology | 8-K: Current report

Apr 17, 2023 21:14

Ikena Oncology | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 14, 2023 20:23